Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study

Rheumatoid Arthritis

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study

Rheumatology (Oxford).

Montastruc F, Renoux C, Dell'Aniello S, Simon TA, Azoulay L, Hudson M, Suissa S

doi: 10.1093/rheumatology/key352.

Rheumatoid Arthritis

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Ann Rheum Dis.

Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC

doi: 10.1136/annrheumdis-

Further Publications Rheumatology

Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model

Rheumatology (Oxford)

Krabbe S, Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Jarbøl DE, Østergaard M, Hetland ML

doi: 10.1093/rheumatology/keaa876

Further Publications Rheumatology

Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study

Semin Arthritis Rheum

Dormuth CR, Fisher A, Hudson M, Austin PC, Ernst P, Bresee L, Chateau D, Tamim H, Paterson JM, Lafrance JP, Taylor-Gjevre RM, Platt RW, Canadian Network For Observational Drug Effect Studies Cnodes Investigators

doi: 10.1016/j.semarthrit.2021.08.002

Psoriatic Arthritis

Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study

Rheumatology (Oxford).

Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith C, McHugh N; PROMPT study group

doi: 10.1093/rheumatology/key286.

Rheumatoid Arthritis

Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data

BMJ Open.

Huang CM, Chen HJ, Huang PH, Tsay GJ, Lan JL, Sung FC

doi: 10.1136/bmjopen2017-

Juvenile Idiopathic ArthritisPsoriatic Arthritis

Risk of Hospitalized Serious Infection After Initiating Ustekinumab or Other Biologics for Psoriasis or Psoriatic Arthritis

Arthritis Care Res (Hoboken)

Jin Y, Lee H, Lee MP, Landon JE, Merola JF, Desai RJ, Kim SC

doi: 10.1002/acr.24630

Rheumatoid ArthritisSpinal Disorders

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

Arthritis Res Ther.

Vinson D, Molet-Benhamou L, Degboé Y, den Broeder A, Ibrahim F, Pontes C, Westhovens R, Závada J, Pham T, Barnetche T, Constantin A, Ruyssen-Witrand A

doi: 10.1186/s13075-020-02188-x.

Psoriatic ArthritisRheumatoid ArthritisSystemic Lupus Erythematosus

Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study

BMJ.

Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y, Dejene SZ, Cohen J, Mogun H, Kim SC

doi: 10.1136/bmj.j895.

Related content

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model

Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study

Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study

Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data

Risk of Hospitalized Serious Infection After Initiating Ustekinumab or Other Biologics for Psoriasis or Psoriatic Arthritis

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study